Results reported this summer are a genuine step forward. They also make the difference between pathology and function impossible to ignore.
At the largest dementia research conference of the year, held in London this July, blood testing was the story. Two findings stood out, and together they change what an ordinary person can expect from their doctor.
What Did the Research Show?
The first finding was about accuracy in ordinary practice. In a study of around 1,300 patients in Sweden, adding a blood biomarker test raised diagnostic accuracy among primary care physicians from about 65% to about 93%. Among specialists it rose from 74% to 89%. That is a large improvement in exactly the setting where most people are first seen.
The second was about timing. In older adults with no symptoms at all, those with the highest levels of one marker had roughly a 78% chance of developing cognitive impairment within ten years, and about a one in three chance within five.
Should You Ask for One?
Probably not yet, and not because the science is weak.
These tests are cleared for people who already have symptoms, assessed by doctors who specialize in memory. Knowing you have a raised risk of something there is no treatment to prevent is a heavy thing to carry, and it is a decision to make with a clinician rather than on a whim.
Why Does This Not Replace a Memory Test?
Because the two measure different things, and the distinction gets sharper the better the blood tests become.
A blood test reports what is accumulating in your brain. A memory test reports how you are functioning. You can have the first without the second for years, which is the entire point of the ten-year prediction above. And you can have memory trouble with no amyloid at all, from causes that are often treatable.
What you actually live with is the second one.
Where This Information Comes From
Findings reported at the Alzheimer's Association International Conference, London, July 2026, and published in JAMA. Conference summaries at aaic.alz.org.